Phocas Financial’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
Phocas Financial's CYTK Position: Q3 2026 in Review
Phocas Financial sold out of Cytokinetics (CYTK) in Q3 2026, closing a stake of 24,634 shares — an estimated $2.1M sold.
Phocas Financial first reported a position in CYTK in Q2 2026 and held it in 1 quarter. The position peaked at $2.1M in Q2 2026. 468 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- Phocas Financial reported no remaining Cytokinetics position as of Q3 2026 after selling out during the quarter.
- Phocas Financial sold 24,634 Cytokinetics shares in Q3 2026, an estimated $2.1M.
- Phocas Financial first reported a position in Cytokinetics in Q2 2026 and held it in 1 quarter.
- Phocas Financial's Cytokinetics position peaked at $2.1M in Q2 2026.
- 468 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on Phocas Financial's 13F filing for Q3 2026.